Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteActive in the last 2 years

Yosuke Mukai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4951-8033; OpenAlex author ID A5101921727. Sources: OpenAlex.

Their work

Papers
11 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 3 papers · 2026: 1 paper

Papers 11

  1. A soft tissue mass around the arteries after pancreatectomy: the association with local recurrence and the impact of neoadjuvant radiotherapy in pancreatic duc… Co-author DOI 10.1007/s00595-026-03341-w↗
  2. Response to letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or b… First author DOI 10.1016/j.surg.2024.109053↗
  3. Reply to letter to editor by yinfang Wu, MM about our manuscript, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from ra… First author DOI 10.1016/j.surg.2024.109132↗
  4. Reply to letter to editor by Duo Yun, MD regarding our article, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radi… First author DOI 10.1016/j.surg.2024.11.003↗
  5. A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic ca… First author DOI 10.1016/j.surg.2024.06.049↗
  6. The preliminary analysis of lymphatic flow around the connective tissues surrounding SMA and SpA elucidates patients' oncological condition in borderline-resec… Co-author DOI 10.1186/s12893-024-02398-z↗
  7. ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radi… Co-author DOI 10.1245/s10434-024-15021-5↗
  8. DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Co-author DOI 10.1186/s12885-023-10512-2↗
  9. Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy. Co-author DOI 10.1245/s10434-018-6431-8↗
  10. ASO Author Reflections: Regulation of Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma by Vitamin D Supplementation. Co-author DOI 10.1245/s10434-018-6891-x↗
  11. Patients Treated with Preoperative Chemoradiation for Pancreatic Ductal Adenocarcinoma have Impaired Bone Density, a Predictor of Distant Metastasis. Co-author DOI 10.1245/s10434-017-6040-y↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hirofumi Akita · 8 shared papers, 2023–2026 · strength 2.06
  2. Masahiko Kubo · 4 shared papers, 2024–2025 · strength 1.27
  3. Hiroshi Wada · 4 shared papers, 2024–2025 · strength 1.27
  4. Shinichiro Hasegawa · 5 shared papers, 2023–2026 · strength 0.96
  5. Hidetoshi Eguchi · 5 shared papers, 2017–2026 · strength 0.76
  6. Daisaku Yamada · 5 shared papers, 2017–2026 · strength 0.72
  7. Hidenori Takahashi · 4 shared papers, 2023–2024 · strength 0.69
  8. Yuichiro Doki · 4 shared papers, 2017–2026 · strength 0.59
  9. Yoshito Tomimaru · 2 shared papers, 2024–2026 · strength 0.46
  10. Masato Sakon · 2 shared papers, 2023–2024 · strength 0.34
  11. Yoshifumi Iwagami · 3 shared papers, 2017–2024 · strength 0.32
  12. Keisuke Toya · 1 shared paper, 2026 · strength 0.27
  13. Satoru Miyahara · 1 shared paper, 2024 · strength 0.18
  14. Kazuki Sasaki · 1 shared paper, 2024 · strength 0.18
  15. Manabu Mikamori · 1 shared paper, 2023 · strength 0.13
  16. Osamu Ishikawa · 1 shared paper, 2023 · strength 0.13
  17. Masahiro Tanemura · 2 shared papers, 2017–2018 · strength 0.13
  18. Tadafumi Asaoka · 2 shared papers, 2017–2018 · strength 0.13
  19. Kunihito Gotoh · 2 shared papers, 2017–2018 · strength 0.13
  20. Yutaka Takeda · 2 shared papers, 2017–2018 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.